Smith & Nephew
Corporate

Select your country

Smith & Nephew

Advanced Search
  • Home
  • About Us
  • Innovation & Products
  • Sustainability
  • Investor Centre
  • News & Media
  • Careers
  • Home
  • Sustainability
  • Policies and Principles
  • Economic Contribution Principles
  • Healthcare Economics
  • Biologics and Clinical Therapies
  • EXOGEN
  • Home >
  • Sustainability >
  • Policies and Principles >
  • Economic Contribution Principles >
  • Healthcare Economics >
  • Biologics and Clinical Therapies >
  • EXOGEN
  • EXOGEN
  • DUROLANE
  • Biomaterials
  • Cell based therapies
  • Contact
  • Print
  • Forward

Email this page

close
  1. Mandatory fields are marked with an asterisk [*].

    Tell us who you want to send your mail to Fill in your email details

    Note: Smith & Nephew does not collect or make use of the email addresses or names provided here. They are only used to show the recipient who has sent the message.

    Change your message if you want Change the message if you want to

    1. <recipient name> <address>
    2. <sender name> <address>
    3. <sender name> is sending you a link

    4. <sender name>

    Visitor verfication

Email sent successfully
Error: Check all fields are valid. Exclude special characters from Comments field
Smith
Nephew

EXOGEN


The EXOGEN Bone Healing System utilizes low-intensity ultrasound to accelerate the healing of fresh fractures up to 38% faster than normal healing.  It also is also highly effective for use on non-healing fractures. These fractures are a significant problem and a major cost to healthcare systems around the world. Clearly patients who suffer fractures which will not heal suffer great frustration and anxiety, and treatment from the EXOGEN system provides an improved chance to recover, invaluable for patients who may have previously been largely confined to hospital or their homes.

  • ◊ Trademark of Smith & Nephew
  • Accessibility
  • Terms of Use
  • Copyright & Disclaimer